Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but residual undifferentiated hiPSCs and malignant transformed cells may lead to tumor formation. Here we describe a highly sensitive tumorigenicity assay...
Saved in:
Published in | Scientific reports Vol. 9; no. 1; p. 1881 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
13.02.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but residual undifferentiated hiPSCs and malignant transformed cells may lead to tumor formation. Here we describe a highly sensitive tumorigenicity assay for the detection of these cells in hiPSC-CMs. The soft agar colony formation assay and cell growth analysis were unable to detect malignantly transformed cells in hiPSC-CMs. There were no karyotypic abnormalities during hiPSCs subculture and differentiation. The hiPSC markers TRA1-60 and LIN28 showed the highest sensitivity for detecting undifferentiated hiPSCs among primary cardiomyocytes. Transplantation of hiPSC-CMs with a LIN28-positive fraction > 0.33% resulted in tumor formation in nude rats, whereas no tumors were formed when the fraction was < 0.1%. These findings suggested that combination of these
in vitro
and
in vivo
tumorigenecity assays can verify the safety of hiPSC-CMs for cell transplantation therapy. |
---|---|
AbstractList | Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but residual undifferentiated hiPSCs and malignant transformed cells may lead to tumor formation. Here we describe a highly sensitive tumorigenicity assay for the detection of these cells in hiPSC-CMs. The soft agar colony formation assay and cell growth analysis were unable to detect malignantly transformed cells in hiPSC-CMs. There were no karyotypic abnormalities during hiPSCs subculture and differentiation. The hiPSC markers TRA1-60 and LIN28 showed the highest sensitivity for detecting undifferentiated hiPSCs among primary cardiomyocytes. Transplantation of hiPSC-CMs with a LIN28-positive fraction > 0.33% resulted in tumor formation in nude rats, whereas no tumors were formed when the fraction was < 0.1%. These findings suggested that combination of these
in vitro
and
in vivo
tumorigenecity assays can verify the safety of hiPSC-CMs for cell transplantation therapy. Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but residual undifferentiated hiPSCs and malignant transformed cells may lead to tumor formation. Here we describe a highly sensitive tumorigenicity assay for the detection of these cells in hiPSC-CMs. The soft agar colony formation assay and cell growth analysis were unable to detect malignantly transformed cells in hiPSC-CMs. There were no karyotypic abnormalities during hiPSCs subculture and differentiation. The hiPSC markers TRA1-60 and LIN28 showed the highest sensitivity for detecting undifferentiated hiPSCs among primary cardiomyocytes. Transplantation of hiPSC-CMs with a LIN28-positive fraction > 0.33% resulted in tumor formation in nude rats, whereas no tumors were formed when the fraction was < 0.1%. These findings suggested that combination of these in vitro and in vivo tumorigenecity assays can verify the safety of hiPSC-CMs for cell transplantation therapy. Abstract Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but residual undifferentiated hiPSCs and malignant transformed cells may lead to tumor formation. Here we describe a highly sensitive tumorigenicity assay for the detection of these cells in hiPSC-CMs. The soft agar colony formation assay and cell growth analysis were unable to detect malignantly transformed cells in hiPSC-CMs. There were no karyotypic abnormalities during hiPSCs subculture and differentiation. The hiPSC markers TRA1-60 and LIN28 showed the highest sensitivity for detecting undifferentiated hiPSCs among primary cardiomyocytes. Transplantation of hiPSC-CMs with a LIN28-positive fraction > 0.33% resulted in tumor formation in nude rats, whereas no tumors were formed when the fraction was < 0.1%. These findings suggested that combination of these in vitro and in vivo tumorigenecity assays can verify the safety of hiPSC-CMs for cell transplantation therapy. |
ArticleNumber | 1881 |
Author | Sawa, Yoshiki Kawamura, Ai Yasuda, Satoshi Mochizuki-Oda, Noriko Takeda, Maki Yajima, Shin Miyagawa, Shigeru Sougawa, Nagako Sato, Yoji Ito, Emiko Harada, Akima Iseoka, Hiroko |
Author_xml | – sequence: 1 givenname: Emiko surname: Ito fullname: Ito, Emiko organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 2 givenname: Shigeru surname: Miyagawa fullname: Miyagawa, Shigeru organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 3 givenname: Maki surname: Takeda fullname: Takeda, Maki organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 4 givenname: Ai surname: Kawamura fullname: Kawamura, Ai organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 5 givenname: Akima surname: Harada fullname: Harada, Akima organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 6 givenname: Hiroko surname: Iseoka fullname: Iseoka, Hiroko organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 7 givenname: Shin surname: Yajima fullname: Yajima, Shin organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 8 givenname: Nagako surname: Sougawa fullname: Sougawa, Nagako organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 9 givenname: Noriko surname: Mochizuki-Oda fullname: Mochizuki-Oda, Noriko organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita – sequence: 10 givenname: Satoshi orcidid: 0000-0002-1011-0815 surname: Yasuda fullname: Yasuda, Satoshi organization: Division of Cell-Based Therapeutic Products, National Institute of Health Sciences – sequence: 11 givenname: Yoji surname: Sato fullname: Sato, Yoji organization: Division of Cell-Based Therapeutic Products, National Institute of Health Sciences – sequence: 12 givenname: Yoshiki surname: Sawa fullname: Sawa, Yoshiki email: sawa-p@surg1.med.osaka-u.ac.jp organization: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30760836$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1rFTEUhoNUbK39Ay5kwPXUfH9sBLmoFQoWbNfh3ExymzJ3ck0yLfPvTb1trZtmkwPve55zkvctOpjS5BF6T_ApwUx_KpwIo3tMdM80o6IXr9ARxVz0lFF68Kw-RCel3OB2BDWcmDfokGElsWbyCN1dztuU48ZP0cW6dFAKLJ0vxU81wtiFlLsALo6xQo3TpisQfPOVOg_Rly6F7jpe_Fr1g8_x1g-dgzzEtF2SW2rT7_vdGBu9wWC3G1tRY5reodcBxuJPHu5jdPXt6-XqrD__-f3H6st57wTHtac6GGEMlWvNtWMuOKEEl3g9DJIo6Y0B7MJAFAhGHThgkgFI7Axvv8IxO0af99zdvN76wbVnZRjtLsct5MUmiPZ_ZYrXdpNurWSKc2Ua4OMDIKffsy_V3qQ5T21nS4kyiipNWXPRvcvlVEr24WkCwfY-L7vPy7a87N-8rGhNH57v9tTymE4zsL2hNGna-Pxv9gvYPwjRpc8 |
CitedBy_id | crossref_primary_10_1186_s13287_024_03690_8 crossref_primary_10_1016_j_jcyt_2022_02_005 crossref_primary_10_1016_j_talanta_2022_123990 crossref_primary_10_1038_s41598_022_14273_z crossref_primary_10_1038_s41598_020_69641_4 crossref_primary_10_1111_cpr_13248 crossref_primary_10_1016_j_heliyon_2020_e04423 crossref_primary_10_3389_fcvm_2022_950829 crossref_primary_10_3390_ijms222413674 crossref_primary_10_3390_ijms25073901 crossref_primary_10_1016_j_bbrc_2021_08_065 crossref_primary_10_1172_jci_insight_142000 crossref_primary_10_1038_s41598_023_37235_5 crossref_primary_10_1126_sciadv_aay7629 crossref_primary_10_1016_j_medj_2022_10_003 crossref_primary_10_1007_s11095_021_03067_z crossref_primary_10_3389_fcell_2022_929256 crossref_primary_10_3390_cells8050403 crossref_primary_10_3390_cells9020504 crossref_primary_10_1038_s41598_023_32442_6 crossref_primary_10_1089_cell_2021_0143 crossref_primary_10_1126_scitranslmed_abp8163 crossref_primary_10_3390_ijms25031513 crossref_primary_10_1016_j_stem_2022_11_006 crossref_primary_10_1093_cvr_cvab052 crossref_primary_10_1186_s12943_023_01873_0 crossref_primary_10_1111_cpr_13232 crossref_primary_10_1016_j_jcyt_2019_10_001 crossref_primary_10_3390_cells11233914 crossref_primary_10_1007_s00424_021_02549_8 crossref_primary_10_1242_bio_053348 crossref_primary_10_9794_jspccs_37_73 |
Cites_doi | 10.1016/j.celrep.2014.08.039 10.1073/pnas.1303669110 10.1371/journal.pone.0045532 10.1016/j.bbrc.2012.07.089 10.1016/j.yjmcc.2010.10.026 10.1016/j.biologicals.2015.05.008 10.1016/j.biologicals.2014.11.007 10.2144/04365ST07 10.1161/CIRCRESAHA.117.311080 10.1038/nbt.1554 10.1016/j.scr.2009.02.002 10.1016/j.cell.2007.11.019 10.1371/journal.pone.0024179 10.1038/srep17892 10.3390/jcm4010159 10.1089/ten.tec.2014.0198 10.1038/srep21747 10.1371/journal.pone.0037342 10.1161/CIRCULATIONAHA.111.084343 10.1371/journal.pone.0085336 10.1038/s41598-018-21923-8 |
ContentType | Journal Article |
Copyright | The Author(s) 2019 This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2019 – notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PIMPY PQEST PQQKQ PQUKI PRINS Q9U 5PM |
DOI | 10.1038/s41598-018-38325-5 |
DatabaseName | Springer Nature OA Free Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
ExternalDocumentID | 10_1038_s41598_018_38325_5 30760836 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS EJD ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RIG RNT RNTTT RPM SNYQT UKHRP CGR CUY CVF ECM EIF NPM AAYXX AFPKN CITATION 7XB 8FK K9. PQEST PQUKI PRINS Q9U 5PM |
ID | FETCH-LOGICAL-c540t-28f959926b848c3cfc575460bdd6176e99a0cfd17a532caca363aa60c94383403 |
IEDL.DBID | RPM |
ISSN | 2045-2322 |
IngestDate | Tue Sep 17 21:26:48 EDT 2024 Thu Oct 10 18:07:35 EDT 2024 Fri Aug 23 01:04:18 EDT 2024 Wed Oct 16 00:44:11 EDT 2024 Fri Oct 11 20:46:29 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-28f959926b848c3cfc575460bdd6176e99a0cfd17a532caca363aa60c94383403 |
ORCID | 0000-0002-1011-0815 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374479/ |
PMID | 30760836 |
PQID | 2179727823 |
PQPubID | 2041939 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6374479 proquest_journals_2179727823 crossref_primary_10_1038_s41598_018_38325_5 pubmed_primary_30760836 springer_journals_10_1038_s41598_018_38325_5 |
PublicationCentury | 2000 |
PublicationDate | 2019-02-13 |
PublicationDateYYYYMMDD | 2019-02-13 |
PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2019 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Miyagawa (CR3) 2016; 74 Matsuura (CR22) 2015; 3 Oricchio (CR9) 2014; 25 Yoshida, Yamanaka (CR2) 2017; 120 CR5 Kusakawa, Yasuda, Kuroda, Kawamata, Sato (CR11) 2015; 5 Matsuura (CR21) 2016; 6 Hentze, Soong, Wang, Phillips, Putti, Dunn (CR18) 2009; 2 Seo, Kim, Neau, Sehgal, Lee (CR13) 2011; 6 Kanemura (CR15) 2014; 9 Matsuura (CR20) 2012; 425 Kawamura (CR19) 2012; 11 Lee (CR17) 2013; 110 Kuroda (CR8) 2012; 7 Takahashi (CR4) 2007; 131 Kawamata, Kanemura, Sakai, Takahashi, Go (CR14) 2015; 4 Miura (CR6) 2009; 27 Michal (CR7) 2012; 7 Yoshida, Yamanaka (CR1) 2011; 50 Kono (CR10) 2015; 43 Ke (CR12) 2004; 36 Yasuda, Sato (CR16) 2015; 43 G Michal (38325_CR7) 2012; 7 K Matsuura (38325_CR22) 2015; 3 T Kuroda (38325_CR8) 2012; 7 M Kawamura (38325_CR19) 2012; 11 K Miura (38325_CR6) 2009; 27 K Takahashi (38325_CR4) 2007; 131 H Hentze (38325_CR18) 2009; 2 E Oricchio (38325_CR9) 2014; 25 MO Lee (38325_CR17) 2013; 110 K Matsuura (38325_CR20) 2012; 425 M Seo (38325_CR13) 2011; 6 K Matsuura (38325_CR21) 2016; 6 S Miyagawa (38325_CR3) 2016; 74 S Kusakawa (38325_CR11) 2015; 5 38325_CR5 S Yasuda (38325_CR16) 2015; 43 N Ke (38325_CR12) 2004; 36 S Kawamata (38325_CR14) 2015; 4 Y Yoshida (38325_CR1) 2011; 50 K Kono (38325_CR10) 2015; 43 H Kanemura (38325_CR15) 2014; 9 Y Yoshida (38325_CR2) 2017; 120 |
References_xml | – volume: 25 start-page: 1677 year: 2014 end-page: 1685 ident: CR9 article-title: A cell engineering strategy to enhance the safety of stem cell therapies publication-title: Cell rep. doi: 10.1016/j.celrep.2014.08.039 contributor: fullname: Oricchio – volume: 110 start-page: E3281 year: 2013 end-page: 90 ident: CR17 article-title: Inhibition of pluripotent stem cell-derived teratoma formation by small molecules publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1303669110 contributor: fullname: Lee – volume: 7 start-page: e45532 year: 2012 ident: CR7 article-title: Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny publication-title: PLoS One doi: 10.1371/journal.pone.0045532 contributor: fullname: Michal – volume: 425 start-page: 321 year: 2012 end-page: 7 ident: CR20 article-title: Creation of human cardiac cell sheets using pluripotent stem cells publication-title: Biochem Biophys Res Commun. doi: 10.1016/j.bbrc.2012.07.089 contributor: fullname: Matsuura – volume: 50 start-page: 327 year: 2011 end-page: 332 ident: CR1 article-title: iPS cells: a source of cardiac regeneration publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2010.10.026 contributor: fullname: Yamanaka – volume: 43 start-page: 416 year: 2015 end-page: 21 ident: CR16 article-title: Tumorigenicity assessment of human cell-processed therapeutic products publication-title: Biologicals. doi: 10.1016/j.biologicals.2015.05.008 contributor: fullname: Sato – volume: 74 start-page: 667 year: 2016 end-page: 70 ident: CR3 article-title: Translational research in iPS cell derived cardiomyocyte sheet for the treatment of heart failure publication-title: Nihon Rinsho. contributor: fullname: Miyagawa – volume: 43 start-page: 146 year: 2015 end-page: 9 ident: CR10 article-title: Characterization of the cell growth analysis for detection of immortal cellular impurities in human mesenchymal stem cells publication-title: Biologicals. doi: 10.1016/j.biologicals.2014.11.007 contributor: fullname: Kono – volume: 36 start-page: 826 year: 2004 end-page: 8 ident: CR12 article-title: One-week 96-well soft agar growth assay for cancer target validation publication-title: Biotechniques. doi: 10.2144/04365ST07 contributor: fullname: Ke – volume: 120 start-page: 1958 year: 2017 end-page: 1968 ident: CR2 article-title: Induced pluripotent stem cells 10 years later: for cardiac applications publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.311080 contributor: fullname: Yamanaka – volume: 27 start-page: 743 year: 2009 end-page: 5 ident: CR6 article-title: Variation in the safety of induced pluripotent stem cell lines publication-title: Nat Biotechnol. doi: 10.1038/nbt.1554 contributor: fullname: Miura – volume: 2 start-page: 198 year: 2009 end-page: 210 ident: CR18 article-title: Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies publication-title: Stem Cell Res. doi: 10.1016/j.scr.2009.02.002 contributor: fullname: Dunn – volume: 131 start-page: 861 year: 2007 end-page: 72 ident: CR4 article-title: Induction of pluripotent stem cells from adult human fibroblasts by defined factors publication-title: Cell. doi: 10.1016/j.cell.2007.11.019 contributor: fullname: Takahashi – volume: 6 start-page: e24179 year: 2011 ident: CR13 article-title: Structure-based development of small molecule PFKFB3 inhibitors: a framework for potential cancer therapeutic agents targeting the Warburg effect publication-title: PLoS One doi: 10.1371/journal.pone.0024179 contributor: fullname: Lee – volume: 5 year: 2015 ident: CR11 article-title: Ultra-sensitive detection of tumorigenic cellular impurities in human cell-processed therapeutic products by digital analysis of soft agar colony formation publication-title: Sci Rep. doi: 10.1038/srep17892 contributor: fullname: Sato – volume: 4 start-page: 159 year: 2015 end-page: 71 ident: CR14 article-title: Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products publication-title: J Clin Med. doi: 10.3390/jcm4010159 contributor: fullname: Go – volume: 3 start-page: 330 year: 2015 end-page: 8 ident: CR22 article-title: Elimination of remaining undifferentiated induced pluripotent stem cells in the process of human cardiac cell sheet fabrication using a methionine-free culture condition publication-title: Tissue Eng Part C methods. doi: 10.1089/ten.tec.2014.0198 contributor: fullname: Matsuura – ident: CR5 – volume: 6 year: 2016 ident: CR21 article-title: Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes publication-title: Sci Rep. doi: 10.1038/srep21747 contributor: fullname: Matsuura – volume: 7 start-page: e37342 year: 2012 ident: CR8 article-title: Highly sensitive methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells publication-title: PLoS One doi: 10.1371/journal.pone.0037342 contributor: fullname: Kuroda – volume: 11 start-page: S29 year: 2012 end-page: 37 ident: CR19 article-title: Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.111.084343 contributor: fullname: Kawamura – volume: 9 start-page: e85336 year: 2014 ident: CR15 article-title: Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration publication-title: PLoS One doi: 10.1371/journal.pone.0085336 contributor: fullname: Kanemura – volume: 36 start-page: 826 year: 2004 ident: 38325_CR12 publication-title: Biotechniques. doi: 10.2144/04365ST07 contributor: fullname: N Ke – volume: 5 year: 2015 ident: 38325_CR11 publication-title: Sci Rep. doi: 10.1038/srep17892 contributor: fullname: S Kusakawa – volume: 74 start-page: 667 year: 2016 ident: 38325_CR3 publication-title: Nihon Rinsho. contributor: fullname: S Miyagawa – volume: 2 start-page: 198 year: 2009 ident: 38325_CR18 publication-title: Stem Cell Res. doi: 10.1016/j.scr.2009.02.002 contributor: fullname: H Hentze – volume: 6 start-page: e24179 year: 2011 ident: 38325_CR13 publication-title: PLoS One doi: 10.1371/journal.pone.0024179 contributor: fullname: M Seo – volume: 7 start-page: e37342 year: 2012 ident: 38325_CR8 publication-title: PLoS One doi: 10.1371/journal.pone.0037342 contributor: fullname: T Kuroda – volume: 43 start-page: 416 year: 2015 ident: 38325_CR16 publication-title: Biologicals. doi: 10.1016/j.biologicals.2015.05.008 contributor: fullname: S Yasuda – volume: 11 start-page: S29 year: 2012 ident: 38325_CR19 publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.111.084343 contributor: fullname: M Kawamura – volume: 4 start-page: 159 year: 2015 ident: 38325_CR14 publication-title: J Clin Med. doi: 10.3390/jcm4010159 contributor: fullname: S Kawamata – volume: 110 start-page: E3281 year: 2013 ident: 38325_CR17 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1303669110 contributor: fullname: MO Lee – volume: 43 start-page: 146 year: 2015 ident: 38325_CR10 publication-title: Biologicals. doi: 10.1016/j.biologicals.2014.11.007 contributor: fullname: K Kono – volume: 9 start-page: e85336 year: 2014 ident: 38325_CR15 publication-title: PLoS One doi: 10.1371/journal.pone.0085336 contributor: fullname: H Kanemura – volume: 425 start-page: 321 year: 2012 ident: 38325_CR20 publication-title: Biochem Biophys Res Commun. doi: 10.1016/j.bbrc.2012.07.089 contributor: fullname: K Matsuura – volume: 6 year: 2016 ident: 38325_CR21 publication-title: Sci Rep. doi: 10.1038/srep21747 contributor: fullname: K Matsuura – volume: 120 start-page: 1958 year: 2017 ident: 38325_CR2 publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.311080 contributor: fullname: Y Yoshida – ident: 38325_CR5 doi: 10.1038/s41598-018-21923-8 – volume: 3 start-page: 330 year: 2015 ident: 38325_CR22 publication-title: Tissue Eng Part C methods. doi: 10.1089/ten.tec.2014.0198 contributor: fullname: K Matsuura – volume: 7 start-page: e45532 year: 2012 ident: 38325_CR7 publication-title: PLoS One doi: 10.1371/journal.pone.0045532 contributor: fullname: G Michal – volume: 25 start-page: 1677 year: 2014 ident: 38325_CR9 publication-title: Cell rep. doi: 10.1016/j.celrep.2014.08.039 contributor: fullname: E Oricchio – volume: 50 start-page: 327 year: 2011 ident: 38325_CR1 publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2010.10.026 contributor: fullname: Y Yoshida – volume: 131 start-page: 861 year: 2007 ident: 38325_CR4 publication-title: Cell. doi: 10.1016/j.cell.2007.11.019 contributor: fullname: K Takahashi – volume: 27 start-page: 743 year: 2009 ident: 38325_CR6 publication-title: Nat Biotechnol. doi: 10.1038/nbt.1554 contributor: fullname: K Miura |
SSID | ssj0000529419 |
Score | 2.4699707 |
Snippet | Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but residual... Abstract Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1881 |
SubjectTerms | 13 13/100 13/31 13/51 38 38/77 631/532/1360 631/532/2064/2158 64 64/60 Animals Carcinogenicity Tests - methods Cardiomyocytes Cell Differentiation Cell Proliferation Cells, Cultured Congestive heart failure Humanities and Social Sciences Humans Induced Pluripotent Stem Cells - cytology Induced Pluripotent Stem Cells - metabolism Karyotype Membrane Glycoproteins - metabolism multidisciplinary Myocytes, Cardiac - cytology Myocytes, Cardiac - metabolism Myocytes, Cardiac - transplantation Neoplasms - etiology Pluripotency Rats Rats, Nude RNA-Binding Proteins - metabolism Science Science (multidisciplinary) Stem cells Subculture Transformed cells Transplantation Transplantation - adverse effects Tumorigenicity Tumors |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwELVaEFIvVT-gTQuVD70VCzv-PiFAIIRUhFqQuEW245SVSpY2S6v994wTZ2GLyjmObeV5PC9-4xmEPpeepfAFsLQoPRGe6mRzmgSuaZBSN6qXYr6equMLcXIpL_OBW5fDKsc9sd-o62lIZ-Q7QJ2hS_BnfPfmF0lVo5K6mktoPEerJRNJpl3dPzw9-7Y4ZUk6lmA235ah3Ox04LHSrTJmCPyclZLIZY_0iGY-jpb8RzLtPdHRK_QyU0i8N2D-Gj2L7Ru0NhSVnL9Ff89vr9PEYzsJQLExsGM3xylFeAvW_BMDS8WNCzk7d_sDd66J0K4bIgrxtMFXk7PvB6SGxfkn1jj0IavX82mYAy_t3x_vU-IH-vc6ujg6PD84Jrm8AglA02akNI2V1pbKG2ECD00A6iYU9XUNtEZFax0NTc20k7wMLjiuuHOKBpvSmwrKN9BKO23je4S1rJ0zjDbAX0TNIrBQcL7MGyq9oD4U6Mv4iaubIYtG1avf3FQDIBUAUvWAVLJAmyMKVbaorrrHv0DvBkAWXfEkLxquCqSXoFo0SDm0l5-0k6s-l7biWghtC7Q9gno_5P9n-OHpGX5EL4BX2RTczfgmWpn9vo1bwF1m_lNeoHdvau9X priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BFYgLassrlFY-cIOAE9txfEBVhUCoEhVSWYlbZDsOuxJkW3Z55N8zjhPevfQcO47yzWg-a2a-AdhKTeLLF9DTnDAxN1R6n5OxZZJaIWSVtamYk1_Z8YD_PBfnM9CPO-p-4OTdq52fJzW4vty9_9t8R4ffDy3j-d4Eg5BvFEvyGO9bqYjFLHxIOePe4k86uh-0vlPFE9X1zry_dREWmM9WBdHmZ6HqDf98W0b5Kpfahqijj7DUcUvyIxjDJ5hx9WeYD9Mmm2W4O7u58nOwXD2yyL0J0mbdEK8dXqObXxKkr6TStpPtri_IRFcO101CqSEZV2Q4Ov19EJdotbeuJLatZb1qxrZBwtru7xstybPE-AoMjg7PDo7jbu5CbJG_TeM0r5RQKs1MznPLbGWR0_GMmrJEvpM5pTS1VZlILVhqtdUsY1pn1Cqve8opW4W5ely7dSBSlFrnCa2Q2PAycUhPMSonJqfCcGpsBNv9Ly7-BHmNok2Ls7wI2BSITdFiU4gINnsUit5SCrxToa0h0WERrAVAHl_VIxmBfAHV4wIvrv3yST0atiLbGZOcSxXBTg_q05H__sKN_z7oCywiF1O-IDxhmzA3vb5xX5HvTM231ogfACpU_oI priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5REBIX1PIMj8qH3iDCjt9HtCpClYqQAIlbZDsOrATZqruA9t8zTrLbboFDz7GTKN-M5nNm5huAb4VnqXwBPS1KnwtPdfI5nQeuaZBS16pNxfy8UOc34setvO1lclIvzEL-npuTMQaY1ATGTI5nqULm8hOsSKZosuCBGsz_p6SMlWC274t5f-ti7HlDKN_WRf6THG1jztlnWO_JIjnt0P0CS7HZgNVufOR0E16unx7TYKvYDAOSaYI82E1JEgNv0G8fCPJRUrvQ63A3d2Ts6ojrxl3tIBnV5H54eTXIKzTD51iR0BanPk5HYYoMtN0_65wkf2W6t-Dm7Pv14DzvBynkAQnZJC9MbaW1hfJGmMBDHZCkCUV9VSGBUdFaR0NdMe0kL4ILjivunKLBJiFTQfk2LDejJu4C0bJyzjBaI1MRFYvINzHMMm-o9IL6kMHR7BOXvzq9jLLNc3NTdoCUCEjZAlLKDA5mKJS974xLPCSh8SBz4RnsdIDMb8VTItFwlYFegGq-IKllL15phvetarbiWghtMziegfrnkR-_4d7_Ld-HNWRUNpV1M34Ay5PfT_EQWcvEf23N9RUf_Obi priority: 102 providerName: Springer Nature |
Title | Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application |
URI | https://link.springer.com/article/10.1038/s41598-018-38325-5 https://www.ncbi.nlm.nih.gov/pubmed/30760836 https://www.proquest.com/docview/2179727823 https://pubmed.ncbi.nlm.nih.gov/PMC6374479 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEB2SlEIvpemn22TRobfWWdmSLOnYmoQQ2LC0CezNSLLcLGS9obtp2X_fkWynm4ZecjEYy7bwm0FPnpk3AB9zm4X0BfQ0L2zKLZXB52TqmKROCNkUMRQzOS9OL_nZTMx2QAy1MDFp39n5UXu9OGrnVzG38mbhxkOe2Hg6KQsmOZd6vAu7krGtLXon6J1rnum-QIYyNV7hIhUKyTKV4n4sF2loV8NCSKpTZt5ajx6QzIe5kv8ETOM6dPICnvcEknzpJroPO759CU-7lpKbV_D74nYRml35du6QYBPkxmZDgkB4i758TZCjksa4Xpu7_UFWpvE4btXlE5JlQ67m0-9lWqNp_vI1cTFhdbFZug2y0nj_UE1JtqLfr-Hy5PiiPE375gqpQ5K2TnPVaKF1XljFlWOucUjceEFtXSOpKbzWhrqmzqQRLHfGGVYwYwrqdBA35ZS9gb122fp3QKSojVEZbZC98DrzyEFx6c2sosJyal0Cn4ZPXN10GhpVjH0zVXXYVIhNFbGpRAIHAwpV70-rCjdOaFDIZlgCbztA7h41IJmAvAfV3YCgoH3_ChpWVNLuDSmBzwOof1_5_xm-f_SLPsAzJFw6ZH1n7AD21j9v_SGSmrUdoSnP5AiefD0-n37Ds7IoR_EHAR4nXI2ikf8BlCD8Hg |
link.rule.ids | 230,315,733,786,790,870,891,12083,21416,24346,27955,27956,31752,33777,41153,42222,43343,43838,51609,53825,53827,74100,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgCMEF8d3QAj5wA6tO_H2qUEW1QFshsZX2ZtmOQ1dqs4VsQfvvGTvJlqWCcxzbyvN4XvzGMwi9qXyZwhfA0qLwhHuqks0pEpiiQQjVyCzFHJ_IySn_NBOz4cCtG8Iqxz0xb9T1IqQz8j2gztAl-DO2f_mdpKpRSV0dSmjcRnc4YzytczVT6zOWpGLx0gx3ZSjTex34q3SnrNQEfs0qQcSmP7pBMm_GSv4lmGY_dPgQPRgIJH7fI_4I3YrtY3S3Lym5eoJ-Ta8u0rRjOw9AsDFwY7fCKUF4C7Z8joGj4saFITd3-w13ronQruvjCfGiwWfzL18PSA1L82esccgBqxerRVgBK83vj7cp8R_q91N0evhhejAhQ3EFEoCkLUmlGyOMqaTXXAcWmgDEjUvq6xpIjYzGOBqaulROsCq44JhkzkkaTEpuyil7hrbaRRu3EVaidk6XtAH2wusyAgcF11t6TYXn1IcCvR0_sb3sc2jYrH0zbXtALABiMyBWFGh3RMEO9tTZa_QL9LwHZN0VS-KiZrJAagOqdYOUQXvzSTs_y5m0JVOcK1OgdyOo10P-e4Yv_j_D1-jeZHp8ZI8-nnzeQfeBYZkU5l2yXbS1_HEVXwKLWfpXean-BsR18N4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BEYgL4ruBAj5wA2ud2I7jE0JtV-WrqkQr7c1yHIeu1GYL2YL23zN2nC1LBec4jpU343nJPM8AvC7qPMgX0NO8rKmomQo-p6jjijkpVVvGVMyXw_LgRHycyVnSP_VJVjnuiXGjbhYu_COfIHXGKTGe8UmbZBFHe9N3F99p6CAVMq2pncZNuIVRkoU2Dmqm1v9bQkZL5Dqdm2G8mvQYu8L5sryi-JlWSCo3Y9M1wnldN_lX8jTGpOl9uJfIJHk_oP8AbvjuIdwe2kuuHsGv48vzsGzfzR2SbYI82a5IKBbeoV-fEeSrpLUu1enuvpHeth7H9YO2kCxacjo_-rpLGzTTn74hLopXz1cLt0KGGu8fT1aSPzLhj-Fkun-8e0BTowXqkLAtaVG1WmpdlHUlKsdd65DEiZLVTYMEp_RaW-baJldW8sJZZ3nJrS2Z06HQqWD8CWx1i85vA1GysbbKWYtMRjS5Rz6KYTivKyZrwWqXwZvxFZuLoZ6GiXlwXpkBEIOAmAiIkRnsjCiY5Fu9ubKEDJ4OgKyn4iHRWPEyA7UB1XpAqKa9eaWbn8aq2iVXQiidwdsR1KtH_nuFz_6_wldwB63UfP5w-Ok53EWypYPiO-c7sLX8celfIKFZ1i-jpf4G1Xj1Cg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumorigenicity+assay+essential+for+facilitating+safety+studies+of+hiPSC-derived+cardiomyocytes+for+clinical+application&rft.jtitle=Scientific+reports&rft.au=Ito%2C+Emiko&rft.au=Miyagawa%2C+Shigeru&rft.au=Takeda%2C+Maki&rft.au=Kawamura%2C+Ai&rft.date=2019-02-13&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=9&rft_id=info:doi/10.1038%2Fs41598-018-38325-5&rft_id=info%3Apmid%2F30760836&rft.externalDBID=PMC6374479 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |